What they were paid
BIOGEN Director Compensation Table · all 3 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $155,000 | $299,947 | $0 | $5,000 | $459,947 |
| FY2024 | $169,389 | $300,160 | $0 | — | $469,549 |
| FY2023 | $162,912 | $270,317 | $0 | — | $433,229 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: BIOGEN INC. DEF 14A filed April 28, 2026, accession 0001193125-26-187303, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025BIOGEN pays directors a $125,000 cash retainer and $300,000 in RSUs.
Committees
FY2025 · as the proxy prints themCompensation (Chair)
The rest of the BIOGEN board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Caroline D. Dorsa | Chair of the Board | $629,930 |
| Christopher A. Viehbacher | Director | $0 |
| Eric K. Rowinsky | Independent Director | $454,947 |
| Lloyd Minor | Independent Director | $439,947 |
| Maria C. Freire | Independent Director | $457,447 |
| Menelas Pangalos | Independent Director | $439,947 |
| Monish Patolawala | Independent Director | $447,447 |
| Stephen A. Sherwin | Independent Director | $439,947 |
| Susan K. Langer | Independent Director | $439,947 |
| William A. Hawkins | Independent Director | $462,447 |
The full BIOGEN compensation record
free company briefThis page is one director within BIOGEN's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat